EE200200420A - Linesoliid - kristallivorm II - Google Patents

Linesoliid - kristallivorm II

Info

Publication number: EE200200420A
Authority: EE; Estonia
Prior art keywords: linezolid; crystalline form; crystalline
Prior art date: 2000-02-02

Application number

EEP200200420A

Other languages

English (en)

Inventor

S. Bergren Michael

Original Assignee

Pharmacia & Upjohn Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-02

Filing date

2001-01-29

Publication date

2003-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22658183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200420(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-01-29 Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company

2003-12-15 Publication of EE200200420A publication Critical patent/EE200200420A/et

2009-08-17 Publication of EE05197B1 publication Critical patent/EE05197B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Plural Heterocyclic Compounds (AREA)

EEP200200420A 2000-02-02 2001-01-29 Linesoliid - kristallivorm II EE05197B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17983700P	2000-02-02	2000-02-02
PCT/US2001/000657 WO2001057035A1 (en)	2000-02-02	2001-01-29	Linezolid-crystal form ii

Publications (2)

Publication Number	Publication Date
EE200200420A true EE200200420A (et)	2003-12-15
EE05197B1 EE05197B1 (et)	2009-08-17

Family

ID=22658183

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200200420A EE05197B1 (et)	2000-02-02	2001-01-29	Linesoliid - kristallivorm II

Country Status (30)

Country	Link
EP (1)	EP1255754B1 (et)
JP (1)	JP5235256B2 (et)
KR (3)	KR100864745B1 (et)
CN (1)	CN1221547C (et)
AR (1)	AR027261A1 (et)
AT (1)	ATE297920T1 (et)
AU (1)	AU782138B2 (et)
BR (1)	BR0107667A (et)
CA (1)	CA2395603C (et)
CO (1)	CO5261555A1 (et)
CZ (1)	CZ302292B6 (et)
DE (1)	DE60111497T2 (et)
DK (1)	DK1255754T3 (et)
EA (1)	EA004434B1 (et)
EE (1)	EE05197B1 (et)
ES (1)	ES2242728T3 (et)
HU (1)	HUP0301076A3 (et)
IL (1)	IL151010A0 (et)
MX (1)	MXPA02007471A (et)
MY (1)	MY122829A (et)
NO (2)	NO323459B1 (et)
NZ (1)	NZ520541A (et)
PE (1)	PE20011086A1 (et)
PL (1)	PL356433A1 (et)
PT (1)	PT1255754E (et)
SI (1)	SI1255754T1 (et)
SK (1)	SK287025B6 (et)
TW (1)	TWI297687B (et)
WO (1)	WO2001057035A1 (et)
ZA (1)	ZA200205162B (et)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100490643B1 (ko) *	2002-10-29	2005-05-19	한국과학기술연구원	새로운 메틸리덴 피페리딘일 옥사졸리딘온 유도체 및이들의 제조방법
EP2902386B1 (en)	2003-10-16	2020-04-08	Symed Labs Limited	A crystalline form of linezolid
US7307163B2 (en)	2004-04-19	2007-12-11	Symed Labs Limited	Process for the preparation of linezolid and related compounds
EP2174935A1 (en) *	2004-06-29	2010-04-14	Teva Pharmaceutical Industries Ltd	Linezolid Compositions
CA2572207A1 (en) *	2004-06-29	2006-10-19	Teva Pharmaceutical Industries Ltd.	Solid forms of linezolid and processes for preparation thereof
US7291614B2 (en)	2005-02-24	2007-11-06	Teva Pharmaceutical Industries Ltd.	Processes for the preparation of linezolid intermediate
EP1893195A2 (en) *	2005-06-22	2008-03-05	Teva Pharmaceutical Industries Ltd	Polymorphic forms of tegaserod maleate
US20070020329A1 (en) *	2005-07-20	2007-01-25	Ruth Tenengauzer	Methods of formulating linezolid
WO2007102082A1 (en) *	2006-03-09	2007-09-13	Glenmark Pharmaceuticals Limited	High oxazolidinone content solid dosage forms
WO2008127300A2 (en) *	2006-10-23	2008-10-23	Concert Pharmaceuticals Inc.	Oxazolidinone derivatives and methods of use
WO2011050826A1 (en)	2009-10-28	2011-05-05	Synthon B.V.	Process for making crystalline form a of linezolid
MX2012012627A (es)	2010-04-30	2013-05-09	Univ Indiana Res & Tech Corp	Proceso para preparar linezolid.
EP2603505A1 (en)	2010-08-11	2013-06-19	Synthon BV	Process for making linezolid
EP2690100A1 (en)	2010-08-11	2014-01-29	Synhton B.V.	Process for making linezolid
EP2593440A1 (en) *	2011-02-24	2013-05-22	Lee Pharma Limited	Anhydrous linezolid crystalline form-ii
WO2012119653A1 (en)	2011-03-09	2012-09-13	Synthon Bv	Process for making crystalline form a of linezolid
CN102731341A (zh) *	2011-04-13	2012-10-17	上海医药工业研究院	用于制备利奈唑胺的中间体及其制备方法
CN102766106A (zh) *	2011-05-03	2012-11-07	江苏豪森医药集团有限公司	利奈唑胺的新晶型及其制备方法
CN102399200B (zh) *	2011-12-14	2013-12-04	浙江新东港药业股份有限公司	一种利用悬浮结晶法制备利奈唑胺晶型ⅰ的方法
EP2852580A1 (en)	2012-01-24	2015-04-01	Jubilant Life Sciences Ltd.	Improved process for the preparation of stable crystalline form-i of linezolid, substantially free of residual solvent
WO2013120496A1 (en)	2012-02-14	2013-08-22	Pharmathen S.A.	Process for the preparation of linezolid in crystalline form and salts thereof
CN102643245A (zh) *	2012-04-10	2012-08-22	杭州华东医药集团生物工程研究所有限公司	一种利奈唑胺晶型及其制备方法
EP2917189B1 (en)	2012-11-09	2016-08-17	Synthon BV	Process for making linezolid
KR102615354B1 (ko)	2016-11-16	2023-12-21	페르시카 파마슈티컬스 리미티드	요통을 위한 항생제 제형
AU2018369696B2 (en) *	2017-11-16	2024-02-01	Persica Pharmaceuticals Ltd.	Linezolid formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK283420B6 (sk) *	1992-05-08	2003-07-01	Pharmacia & Upjohn Company	Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) *	1993-09-09	2003-04-30	Upjohn Co	Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) *	1994-08-16	1997-11-18	Pharmacia & Upjohn Company	Substituted oxazine and thiazine oxazolidinone antimicrobials
WO1997037980A1 (en) *	1996-04-11	1997-10-16	Pharmacia & Upjohn Company	Process to prepare oxazolidinones
PL199355B1 (pl) *	1997-11-07	2008-09-30	Upjohn Co	Drugorzędowy (S)-alkohol i sposób jego wytwarzania oraz sposób wytwarzania (S)-3-karboaminoalkoholu

2001
- 2001-01-22 AR ARP010100269A patent/AR027261A1/es not_active Application Discontinuation
- 2001-01-25 PE PE2001000080A patent/PE20011086A1/es not_active Application Discontinuation
- 2001-01-26 CO CO01005901A patent/CO5261555A1/es not_active Application Discontinuation
- 2001-01-29 AU AU32755/01A patent/AU782138B2/en not_active Ceased
- 2001-01-29 AT AT01904805T patent/ATE297920T1/de active
- 2001-01-29 DK DK01904805T patent/DK1255754T3/da active
- 2001-01-29 KR KR1020077016678A patent/KR100864745B1/ko not_active Expired - Fee Related
- 2001-01-29 EE EEP200200420A patent/EE05197B1/et not_active IP Right Cessation
- 2001-01-29 MY MYPI20010371A patent/MY122829A/en unknown
- 2001-01-29 PL PL01356433A patent/PL356433A1/xx unknown
- 2001-01-29 WO PCT/US2001/000657 patent/WO2001057035A1/en not_active Ceased
- 2001-01-29 IL IL15101001A patent/IL151010A0/xx active IP Right Grant
- 2001-01-29 SI SI200130405T patent/SI1255754T1/sl unknown
- 2001-01-29 ES ES01904805T patent/ES2242728T3/es not_active Expired - Lifetime
- 2001-01-29 CZ CZ20022635A patent/CZ302292B6/cs not_active IP Right Cessation
- 2001-01-29 DE DE60111497T patent/DE60111497T2/de not_active Expired - Lifetime
- 2001-01-29 SK SK994-2002A patent/SK287025B6/sk not_active IP Right Cessation
- 2001-01-29 HU HU0301076A patent/HUP0301076A3/hu unknown
- 2001-01-29 MX MXPA02007471A patent/MXPA02007471A/es active IP Right Grant
- 2001-01-29 CA CA2395603A patent/CA2395603C/en not_active Expired - Lifetime
- 2001-01-29 EP EP01904805A patent/EP1255754B1/en not_active Expired - Lifetime
- 2001-01-29 PT PT01904805T patent/PT1255754E/pt unknown
- 2001-01-29 BR BR0107667-1A patent/BR0107667A/pt not_active Application Discontinuation
- 2001-01-29 KR KR1020027009923A patent/KR100781815B1/ko not_active Expired - Fee Related
- 2001-01-29 NZ NZ520541A patent/NZ520541A/en not_active IP Right Cessation
- 2001-01-29 KR KR1020087010742A patent/KR20080044358A/ko not_active Ceased
- 2001-01-29 JP JP2001557867A patent/JP5235256B2/ja not_active Expired - Lifetime
- 2001-01-29 CN CNB018034489A patent/CN1221547C/zh not_active Expired - Fee Related
- 2001-01-29 EA EA200200819A patent/EA004434B1/ru not_active IP Right Cessation
- 2001-02-02 TW TW090102231A patent/TWI297687B/zh not_active IP Right Cessation
2002
- 2002-06-27 ZA ZA200205162A patent/ZA200205162B/en unknown
- 2002-08-01 NO NO20023654A patent/NO323459B1/no not_active IP Right Cessation
2006
- 2006-12-15 NO NO20065836A patent/NO20065836L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SI1255754T1 (sl)	2005-12-31
NO20023654D0 (no)	2002-08-01
NO20065836L (no)	2002-08-01
DE60111497D1 (de)	2005-07-21
KR20020072300A (ko)	2002-09-14
EE05197B1 (et)	2009-08-17
PE20011086A1 (es)	2001-10-04
SK287025B6 (sk)	2009-10-07
AR027261A1 (es)	2003-03-19
AU3275501A (en)	2001-08-14
WO2001057035A1 (en)	2001-08-09
ES2242728T3 (es)	2005-11-16
PT1255754E (pt)	2005-11-30
JP5235256B2 (ja)	2013-07-10
CN1221547C (zh)	2005-10-05
ZA200205162B (en)	2003-09-29
JP2003522175A (ja)	2003-07-22
NZ520541A (en)	2004-02-27
ATE297920T1 (de)	2005-07-15
CA2395603A1 (en)	2001-08-09
KR100781815B1 (ko)	2007-12-03
HK1051196A1 (en)	2003-07-25
KR20070087178A (ko)	2007-08-27
AU782138B2 (en)	2005-07-07
MY122829A (en)	2006-05-31
HUP0301076A3 (en)	2004-06-28
CN1394207A (zh)	2003-01-29
EP1255754A1 (en)	2002-11-13
TWI297687B (en)	2008-06-11
EA004434B1 (ru)	2004-04-29
NO20023654L (no)	2002-08-01
SK9942002A3 (en)	2002-11-06
EP1255754B1 (en)	2005-06-15
CZ20022635A3 (cs)	2002-10-16
MXPA02007471A (es)	2002-12-13
PL356433A1 (en)	2004-06-28
NO323459B1 (no)	2007-05-14
IL151010A0 (en)	2003-02-12
CA2395603C (en)	2010-03-23
CZ302292B6 (cs)	2011-02-09
EA200200819A1 (ru)	2003-02-27
DE60111497T2 (de)	2006-05-18
DK1255754T3 (da)	2005-08-22
HUP0301076A2 (hu)	2003-08-28
KR100864745B1 (ko)	2008-10-22
BR0107667A (pt)	2002-10-08
CO5261555A1 (es)	2003-03-31
KR20080044358A (ko)	2008-05-20

Publication	Publication Date	Title
DE60126645D1 (de)	2007-03-29	Sulfonamidether - substituierte imidazochinoline
DE60131628D1 (de)	2008-01-10	Stenteinführvorrichtung
NO20031949L (no)	2003-07-08	Cyanopyrrolidinderivater
NO20025176D0 (no)	2002-10-28	Multippelstigerörreaktor
NO20013477L (no)	2002-01-16	Brönnrengjöringsverktöy
FI20000570L (fi)	2001-09-11	Monimurtojakajainen esijakaja
ATA2932001A (de)	2004-11-15	Schneefräse
DE50108963D1 (de)	2006-04-20	Schlauchklemme
EP1282428A4 (en)	2007-09-05	BIOCOMPATIBLE MACROMERS
EE05197B1 (et)	2009-08-17	Linesoliid - kristallivorm II
DE60140772D1 (de)	2010-01-21	Bildaufzeichungsverfahren
DE50104056D1 (de)	2004-11-18	Gewichtsmanschette
DE60114748D1 (de)	2005-12-15	Reibschweissverbinden
NO20032371D0 (no)	2003-05-26	Makrolidsolvater
AR028336A1 (es)	2003-05-07	4-hidroxi-tetrahidropiridonas fenilsubstituidas
DE60113739D1 (de)	2006-02-16	Glascontainerplungervorrichtung
DE60102041D1 (de)	2004-03-25	Halbleitervorrichtug
DE60112124D1 (de)	2005-08-25	Klemmring
AR028061A1 (es)	2003-04-23	2-enamino-cetonitrilos fenil-substituidos
AR027982A1 (es)	2003-04-23	Aril- y heteroarilsulfonatos
NO20031357L (no)	2003-03-25	Fenoksyfenylalkansulfonater
ATA7092001A (de)	2004-08-15	Skibindungseinstellgerät
DE50113907D1 (de)	2008-06-12	Entladeschutzvorrichtung
AT500246B8 (de)	2007-02-15	Chokerring
FR2817889B1 (fr)	2003-08-15	Coffrage

Legal Events

Date	Code	Title	Description
2010-04-15	AA1Y	Spc filed	Free format text: PRODUCT NAME: ZYVOX; REG NO/DATE: 00032/0259 05.01.2001 Spc suppl protection certif: C20100003 Filing date: 20100215
2010-08-16	FC1Y	Spc application refused	Free format text: PRODUCT NAME: ZYVOX; REG NO/DATE: 00032/0259 05.01.2001 Spc suppl protection certif: C20100003 Filing date: 20100215
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2012-10-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20120129